Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
VALDOXAN, DOMION, NORTIM and ARDIX AGOMELATINE (Servier Laboratories Australia Pty Ltd)
Product name
VALDOXAN, DOMION, NORTIM and ARDIX AGOMELATINE
Date registered
Evaluation commenced
Decision date
Approval time
185 (255 working days)
Active ingredients
Agomelatine
Registration type
EOI
Indication
Treatment in adults of:
- generalised anxiety disorder (GAD).